Analyses of Persistence, Treatment Duration, and the Patient Journey

Our analyses of persistence, treatment duration, and the patient journey provide you with detailed insights into adherence, as well as discontinuation and continuation rates for your patients across one or multiple treatment cycles. In addition, we offer in-depth views into the sequential progression of therapies, including the distribution of active ingredients and products within each line of treatment.

The persistence analysis evaluates discontinuation and continuation rates among newly initiated patients and is therefore a key indicator for drop-out rates and milestones within the course of therapy. It shows what proportion of new patients remain on their therapy after x months, making it the ideal type of analysis to support product launch activities or track the impact of specific measures. It also enables direct comparisons with competitors.

Precisely determining the duration of therapy in days as well as short-term and long-term treatment, and calculating the number of cycles per patient give you deep clinical insights and actionable findings. You can also directly compare your product’s performance with that of competitors.

Our Patient Journey analyses show you how treatment starts and how it ends. We map the exact order in which products are prescribed and provide a direct comparison of the most common treatment pathways versus less typical therapy courses.

Determining the line of therapy for your products and those of your competitors gives you valuable insights into real-world treatment practice. The actual patient shares per line of therapy can then be compared with clinical guideline recommendations.

Customizable levels of analysis allow you to go beyond product/active ingredient sequences and also examine treatment sequences by involved physician specialty groups, dosage strengths, formulations, and more.